Pharmessen Scientific, Inc. Announces Trading On The OTC And New Stock Symbol.Business Editors SAN DIEGO--(BUSINESS WIRE)--April 21, 2004 Pharmessen Scientific, Inc, a nutraceutical company founded in 2001, announced today that it has begun trading on the OTCPS under the symbol: PASC PASC - Perceptional Adaptive Subband Coding . PHARMESSEN, INC. was founded by its President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Dr. Dusan G. Ninkov. Dr. Ninkov has begun his scientific career twenty years TWENTY YEARS. The lapse of twenty years raises a presumption of certain facts, and after such a time, the party against whom the presumption has been raised, will be required to prove a negative to establish his rights. 2. ago in the field of biomedical research. He has devoted his life to investigating the effects of herbal extracts in the treatment of infectious diseases. The research that has taken place in many different countries all over the world has resulted in the development of several new compounds to fight multi-resistant infectious agents. Presently, PHARMESSEN scientific team is focused on the production of novel dietary supplements and the development of therapeutic medications applicable to Septic Syndrome septic syndrome Sepsis syndrome, see there , eradication of Helicobacter Pylori Helicobacter pylori A gramnegative rod-shaped bacterium that lives in the tissues of the stomach and causes inflammation of the stomach lining. Mentioned in: Indigestion, Ulcers Helicobacter pylori in the stomach, and Nosocomial Infections Nosocomial infections Infections that were not present before the patient came to a hospital, but were acquired by a patient while in the hospital. Mentioned in: Enterobacterial Infections, Staphylococcal Infections . Mr. George Macleod, Chief Executive Officer of Pharmessen Scientific, Inc. stated, "This is a very important step for the future growth of the Company. As a publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. , this will assist us in our marketing capabilities both domestically and internationally while creating an opportunity for shareholder enhancement." About Pharmessen Scientific, Inc. Pharmessen, Inc. is a nutraceutical and pharmaceutical company focused on research, development, production and marketing of natural food supplements and pharmaceutical compounds. Pharmessen's goal is to provide customers with superb products containing active ingredients extracted from organically grown plants provided by reputable suppliers around the globe. Pharmessen's scientific team is presently focused on developing new anti-microbial agents in order to improve the treatments of diseases caused by multi-resistant pathogens, on producing excellent dietary supplements to help athletes improve their performance, and on providing general population interested in healthy life style with natural products of extraordinary quality. Additional information can be found on our website: www.pharmenssen.com or by calling: Investor Relations MacReport.Net, Inc. Mr. Tom Speciale 631-393-5075 www.macreport.net Safe Harbor Statement As a cautionary note to investors, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; Triangle Multi-Media's ability to execute its business model and strategic plans; and the risks described from time to time in the company's Securities and Exchange Commission filings. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion